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Abstract
Two subtypes of estrogen receptors (ER), ERa and ERb, have been identified in humans and numerous vertebrates, including
the Japanese quail. We investigated in this species the specific role(s) of each receptor in the activation of male sexual
behavior and the underlying estrogen-dependent neural plasticity. Castrated male Japanese quail received empty (CX) or
testosterone-filled (T) implants or were daily injected with the ER general agonist diethylstilbestrol (DES), the ERa-specific
agonist PPT, the ERb-specific agonist DPN or the vehicle, propylene glycol. Three days after receiving the first treatment,
subjects were alternatively tested for appetitive (rhythmic cloacal sphincter movements, RCSM) and consummatory aspects
(copulatory behavior) of male sexual behavior. 24 hours after the last behavioral testing, brains were collected and analyzed
for aromatase expression and vasotocinergic innervation in the medial preoptic nucleus. The expression of RCSM was
activated by T and to a lesser extent by DES and PPT but not by the ERbagonist DPN. In parallel, T fully restored the
complete sequence of copulation, DES was partially active and the specific activation of ERa or ERb only resulted in a very
low frequency of mount attempts in few subjects. T increased the volume of the medial preoptic nucleus as measured by
the dense cluster of aromatase-immunoreactive cells and the density of the vasotocinergic innervation within this nucleus.
DES had only a weak action on vasotocinergic fibers and the two specific ER agonists did not affect these neural responses.
Simultaneous activation of both receptors or treatments with higher doses may be required to fully activate sexual behavior
and the associated neurochemical events.
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Introduction
Testosterone, the main steroid hormone produced by the
gonads in male vertebrates, controls a wide range of physiolog-
ical and behavioral responses, including male sexual behavior.
In male quail (Coturnix japonica) like in other vertebrates,
castration completely abolishes copulation while testosterone
(T) treatment fully restores male sexual behavior [1,2]. The
behavioral action of T is largely mediated by its estrogenic and
androgenic metabolites, 17b-estradiol (E2)a n d5 a-dihydrotes-
tosterone (5a-DHT) respectively [3–5]. The conversion of T
into E2 is catalyzed by the enzyme aromatase [6–8] which
exhibits a very discrete distribution in the brain. A very dense
expression of aromatase is notably found in the preoptic area
and the hypothalamus [9–11].
The medial preoptic nucleus, POM is a sexually dimorphic
(males .females) structure located in the medial preoptic area that
plays a critical role in the control of male sexual behavior [12,13].
While specific lesions of the POM completely abolish male sexual
behavior, T implants stereotaxically positioned within the borders
of the POM fully restore this behavior in castrated animals. In
addition, numerous neurochemical markers of the POM are
highly sensitive to circulating T concentrations. For example,
aromatase-immunoreactive cells and vasotocin-immunoreactive
fibers outline the entire POM and their density is significantly
reduced in castrated birds but restored by exogenous T to a
density that is typically seen in sexually mature males [14–17].
Interestingly, like male sexual behavior, the effects of T on
aromatase and vasotocin expression are largely mediated by its
estrogenic metabolites [18,19].
Although numerous studies have also identified non-genomic
or indirect genomic effects associated with the activation of
membrane estrogen receptors [20], neural effects of estrogens
are classically mediated via the activation of nuclear estrogen
receptors (ER) [21]. The binding of E2 or of estrogen agonists to
a nuclear ER induces its dimerization. The activated ER dimer
then recognizes an estrogen response element (EREs) on the
DNA and regulates the transcription of specific target genes
[22–24].
There are two described nuclear estrogen receptor subtypes, a
(ERa) and b (ERb), and they have been identified in many
vertebrate species including the Japanese quail [25–27]. Both
subtypes have a discrete brain distribution that overlaps in
numerous brain regions, including the POM and bed nucleus of
the stria terminalis (BST) in quail [28,29]. A similar distribution
has been identified in mammals [30].
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differentially modulate reproductive and non-reproductive re-
sponses via two different ERs. Early work based on the specific
distribution of the receptors and on specific ER knock-out mice
(ERa ˜KO and bERKO) suggested that ERa was mainly required
for the normal development of reproductive organs, including
uterus and gonads, and for expression of both male and female
sexual behavior and while ERb was responsible for the normal
maintenance of non-reproductive organs such as the cardiovascu-
lar system or bones and for the regulation of social and cognitive
aspects of the behavior (see for example: [32–35]). However, more
recent functional analyses of the receptor actions tend to temper
this simple dichotomy [36,37]. Moreover, it was realized that the
utilization of knockouts to study the distinct roles of ERa and b
was limiting analysis to a single model species, did not discriminate
between organizational and activational effects of the steroids and
was potentially biased by compensatory mechanisms during
development therefore rendering the generalization of ER
function somewhat speculative. For example, the deletion of
ERa differentially affects sexual behavior depending on the mouse
backgrounds [38].
The development of specific receptor agonists allows a different
approach to investigate the distinct functional role of estrogen
receptor subtypes. Propyl-pyrazole-triol (PPT), an ERa specific
ligand, and diarylpropionitrile (DPN), an ERb specific ligand were
developed thanks to the weak sequence identity of the C-terminal
ligand-binding domain shared by two ER molecules, [39,40].
DPN has an approximately 70-fold higher selectivity for ERb over
ERa while PPT is more or less 410 times more selective for ERa
than ERb [41,42]. These compounds have been used to
investigated the role of the two ERs in the control of various
neuroanatomical, neurochemical and behavioral processes, in-
cluding female sexual receptivity or proceptivity [43], aggressive
behavior [44] or learning and memory [45–47] but to our
knowledge, this approach has never been applied to the study of
male sexual behavior.
The goal of the present study was to define the contribution of
each estrogen receptor subtype in the estrogen-dependent
activation of male sexual behavior and the underlying neuroplas-
ticity in Japanese quail. Castrated male Japanese quail were daily
injected with the general ER agonist diethylstilbestrol (DES) or
one of the specific ER agonists and were tested for both appetitive
and consummatory aspects of male sexual behavior. Both aspects
of male-typical sexual behavior are under estrogenic control to a
large extent though the site of estrogen action in activating each
component of male behavior appears to be distinct to some degree
[13,48]. Negative and positive controls were provided by
untreated castrates and by castrates treated with exogenous T.
Two brain estrogen-sensitive responses, the volume of the POM
defined by aromatase-immunoreactive staining and the density of
vasotocin fibers in the POM were also investigated.
Materials and Methods
Animals and hormone treatments
Fifty-two male Japanese quail (Coturnix japonica) obtained from
the breeding colony established in our laboratory were castrated at
the age of three weeks as previously described [49]. Animals were
housed in isolation and allowed to recover for at least 3 weeks. The
subjects were then randomly distributed into six experimental
groups: sixteen subjects were implanted subcutaneously in the
neck region with two 20 mm-long Silastic
TM tubes (Silclear
TM
Tubing, Degania Silicone, 1.57 mm i.d., 2.41 mm o.d.) that were
empty (CX group, n=7) or filled with crystalline testosterone
(Sigma, T group, n=9). These testosterone-filled implants restore
in castrated male quail physiological levels of the steroid that are
typical of sexually mature males and produce a full activation of
male sexual behavior [50]. The remaining birds were injected
daily in the pectoral muscle for 13 days with the general ER
agonist diethylstilbestrol (Sigma; 250 mgi n5 0ml vehicle, DES
group, n=9), the ERa specific agonist 4,49,40-(4-Propyl-[1H]-
pyrazole-1,3,5-triyl) trisphenol (Tocris, 250 mgi n5 0ml vehicle,
PPT group, n=9), the ERb specific agonist 2,3-bis(4-Hydro-
xyphenyl)-propionitrile (Tocris, 250 mgi n5 0 ml vehicle, DPN
group, n=9) or the vehicle propylene glycol (Sigma, 50 ml, PG
group, n=9).
The cloacal gland, an androgen-dependent structure [51,52],
was measured with callipers (greatest width 6 greatest length in
mm
2) before and at the end of the experiment to confirm the
effectiveness of the treatments. The body mass was also recorded
at the same times.
Throughout their life, birds were exposed to a photoperiod
simulating long days (16 h light and 8 h dark per day) and had
food and tap water available ad libitum. All experimental pro-
cedures were in agreement with the Belgian laws on the
‘‘Protection and Welfare of Animals’’ and on the ‘‘Protection of
experimental animals’’ and were approved by the Ethics
Committee for the Use of Animals at the University of Lie `ge.
Behavioral testing and brain collection
The subjects were tested daily, alternatively for copulatory
behavior (consummatory sexual behavior) or for rhythmic cloacal
sphincter movements (appetitive sexual behavior) starting three
days after the beginning of the treatments. The behavioral tests
started approximately 2 h after the daily injection. To assess
consummatory sexual behavior, the experimental bird was
introduced into a test arena (60640650 cm) that contained a
sexually mature female with which the male could freely interact.
During these tests, the frequency of sexual behavior patterns
including neck grabs (NG), mount attempts (MA), mounts (M) and
cloacal contact movements (CCM) (see [53,54] for a detailed
description of these behaviors) was recorded by an observer blind
to the treatment of the birds. Six tests were carried out during the
thirteen experimentation days.
To assess appetitive sexual behavior, the frequency of the
rhythmic cloacal sphincter movements (RCSM) was quantified in
a glass aquarium (40620625 cm) adjacent to another similar
aquarium containing a female [55,56]. A piece of opaque
cardboard was attached to the exterior of the glass wall facing
the experimenter to prevent the subject from being distracted by
the presence of the experimenter. A mirror was placed at a 45u
angle under the cage to allow the experimenter to view the cloacal
area of the subject. A vertically sliding opaque panel was initially
inserted between the two aquaria so that the experimental male
could not see the female located in the second aquarium during
2.5 min. After this time, the sliding opaque panel was raised
during the next 2.5 min. The male had then visual access to the
female although he could not physically interact with her. The
number of RCSM was recorded separately during the two 2.5 min
periods when the male had or had not visual access to the female.
The very low basal RCSM frequency observed in the absence of
the female (usually less than 20) was then subtracted from the
RCSM frequency observed in her presence to obtain a measure of
the female-induced RCSM that is presented in the results. Four
tests were carried out during the thirteen experimentation days.
Twenty-four hours after the last behavioral test and the last
injection, birds were killed by decapitation and checked for the
completeness of castration and presence of Silastic
TM implants
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castrations and all subjects in the CX and CX+T groups still
possessed their hormone implants. Brains were dissected from the
skull, fixed in 5% acroleine in phosphate buffered saline (PBS,
90 min), rinsed twice in buffer and cryoprotected in 30% sucrose
for 48 h. They were then rapidly frozen on dry ice and kept at
280uC until used.
Immunohistochemistry
The brains were cut with a cryostat in the coronal plane from
the level of the tractus septopallio-mesencephalicus to the caudal
end of the tuberal hypothalamus. 30 mm-thick free-floating
sections were collected in four series. Two series were stained by
immunohistochemistry respectively for aromatase (ARO) and
vasotocin (VT) as previously described and validated for quail
(ARO: [11,57]; VT: [16,58]) with slight modifications. Briefly,
sections were incubated for 15 min in 0.1% sodium borohydride
in PBS and washed in PBS (pH 7.3–7.4). Endogenous peroxidase
activity was blocked by incubating the sections for 20 min in 0.6%
hydrogen peroxide, the non-specific antibody binding sites were
blocked with 5% goat normal serum, and the sections were
incubated with the primary antibody at 4uC (rabbit anti-quail
recombinant ARO antibody, QR2/05 (gift from Prof. N. Harada,
Fujita Health University, Toyoake, Japan) 1:3000, overnight
incubation) or rabbit anti-VT antibody (gift from Dr. D.G. Gray,
Max Plank Institute of Bad Nauheim, Germany) 1:5000, 48 hours
incubation). Sections were then left for 2 h in secondary
biotinylated goat anti-rabbit antibody (1:400, Dako A/S, Gosltrup,
Denmark) and finally incubated in ABC Vectastain elite Kit PK-
6100 (Vector Laboratories) for 90 min. All reagents were in
Phosphate-buffered saline 0.05 M containing 0.1% triton X-100
(PBST) and several rinses were performed between each step. The
peroxidase enzymatic activity was then visualized with 3, 39
diaminobenzidine tetrahydrochloride (DAB, 2%), 0.012% hydro-
gen peroxide in PBS (aromatase, ARO) or with DAB (2%), Nickel
sulphate (25 mg/ml), 0.012% hydrogen peroxide in Sodium
Acetate (0.175 M) (vasotocin, VT). Reaction was terminated by
several rinses in PBS and the sections were mounted in an aqueous
gelatin medium (aromatase) or in EukittH quick-hardening
mounting medium (Sigma, vasotocin) and coverslipped.
Image Analysis
Image acquisitions were performed by an observer blind to the
treatment groups using a CCD camera (Model CFW-1612C,
Scion Corporation, MD, USA) attached to an Olympus
microscope and connected to a MacIntosh computer (Software:
ImageJ, Wayne Rasband, NIH, Bethesda, MD, USA). We first
calculated the volume of the medial preoptic nucleus (POM),
defined by aromatase-immunoreactive-cells (See figure 1A.). The
area of the nucleus was measured in all sections containing the
nucleus throughout its rostro-caudal extent (objective 10X). Areas
were then summed and multiplied by the sampling interval
(120 mm; every 4
th 30 mm section was stained) to derive an
estimate of volume. In addition, we analyzed the vasotocinergic
innervation of the POM by calculating the relative optical density
of the immunoreactive signal observed a with a 20 6 objective.
The quantification field (46060.350 mm=0.161 mm
2 at 20X) was
Figure 1. Photomicrographs illustrating the aromatase-immu-
noreactive perikarya (A) and the vasotocin-immunoreactive
fibers (B, C) present within the medial preoptic nucleus (POM)
that were quantified in the present study. Panel A illustrates the
dense group of aromatase-immunoreactive neurons that outline the
entire POM. The dotted line marks the limits of the POM as they were
defined for quantification. Panel B shows the accumulation of
vasotocin-immunoreactive fibers in the POM at the level of the anterior
commissure. The rectangle drawn with a solid line indicates the area
where quantification was performed that is illustrated at higher
magnification in panel C. The dotted rectangle indicates how the
camera field was originally placed before being moved to its final
location (see text). Note that quantification of fibers concerned the
steroid-sensitive network located in the POM, not the denser network
located more ventrally that originates from the magnocellular neurons.
CA: commissural anterior, LFB: latera forebrain bundle. Magnification
bar= 500 mm in A–B, 100 mmi nC .
doi:10.1371/journal.pone.0018627.g001
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commissure and the lateral edge of the third ventricle at the level
where the anterior commissure reaches its largest extension. The
field was then moved one field ventrally (350 mm) and the optical
density of the entire computer field at this location was quantified
(see figure 1B–C). The relative optical density (ROD) was defined
as the difference between of the optical density (gray levels)
measured (after calibration) within the POM and in an equivalent
area located in a vasotocin-free location in the telencephalon on
the same section (background).
Statistical analyses
Preliminary analyses indicated that there was, as expected, no
significant difference between the two control groups (CX and PG)
for all variables considered. Results from these two groups were
thus pooled (CX/PG) in all statistical analyses presented here to
increase their power.
The effects of treatments on the proportion of subjects
displaying a specific behavior at least once during the six
copulatory tests (NG, MA, M, CCM) or one the four RCSM
tests was assessed by Chi square tests. One-tailed Fisher’s exact
probability tests were then used to identify a potential effect of
specific compounds compared to the control group since increases
only could possibly be observed (these behaviors are absent in
castrated birds). The mean cumulative behavioral frequencies
summed over all tests for each subject (active or inactive) were
analyzed by non-parametric Kruskall-Wallis analyses of variance
that were followed when appropriate by the post-hoc comparison
of all experimental groups with the control group with the Dunn’s
test. All statistical results for NG and MA, on the one hand, and
for M and CCM, on another hand, were nearly identical and to
avoid redundancy we shall only present results relative to MA and
CCM.
The size of the cloacal gland, the volume of the POM defined
by aromatase-staining, and the density of vasotocinergic innerva-
tion in the POM were analyzed by parametric one-way analyses of
variance (ANOVA) followed when appropriate by post-hoc
Dunnett’ tests comparing all groups with the controls.
All statistical analyzes were performed with GraphPad Prism
5.0 for MacOS X (GraphPad Software Inc, La Jolla CA) and all
data are expressed as mean 6 SEM. Differences were considered
significant for p,0.05.
Results
Cloacal gland
Steroid treatments significantly affected the size of the cloacal
gland (F(4,47)=59.71; p,0.0001, Figure 2A). Post-hoc compari-
sons by the Dunnett’s multiple comparison test revealed a
significant increase of the cloacal gland area in testosterone-
treated subjects compared to CX/PG control group (p,0.01)
while DPN, PPT and DES groups were not different from this
control group (p.0.05).
Appetitive Sexual Behavior
Treatments significantly influenced the proportion of birds
displaying rhythmic cloacal sphincter movements (x2=17.44,
df=4, p,0.0016). Two control birds showed RCSM very
infrequently and only during one test while a significant number
of birds treated with T (8/9), DES (7/9), PPT (5/9) or DPN (4/9)
displayed this behavior at least during one test even if at low
frequencies in some cases. These numbers of active birds were
significantly higher than in controls in the T (p=0.0003), DES
(p=0.0022) and PPT (p=0.0343) groups but not following
Figure 2. Cloacal gland area (in mm
2) at the end of the
experiment (A), percentage of birds that displayed at least one
female-induced rhythmic cloacal sphincter movement
(RCSM)(B) and cumulative frequencies of these RCSM in the 5
experimental groups (C). Data were analyzed by appropriate
analyses of variance or c2 tests that were followed by post-hoc tests
specifically comparing the 4 experimental groups to the controls (see
text). Results of these post-hoc comparisons are shown at the top of the
bars as follows: *= p,0.05, **= p,0.01 and ***= p,0.001.
doi:10.1371/journal.pone.0018627.g002
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probability tests; see Figure 2B).
In addition, there was a general effect of the treatment on the
RCSM frequency (H=23.52, df=4, p,0.0001; see Figure 2C).
Specific post-hoc comparisons with the control group by the
Dunn’s test only revealed significant differences between the T and
CX/PG groups (p,0.001).
Consummatory Sexual Behavior
The endocrine treatments affected significantly the proportion
of birds displaying MA (x2=25.17, df=4, p,0.0001) and CCM
(x2=34.47, df=4, p,0.0001; Fig. 3A–B). As previously demon-
strated, CX/PG subjects never showed any aspect of consumma-
tory male sexual behavior while most T-treated birds displayed the
full copulatory sequence (MA: 9/9, CCM: 8/9, p,0.0001 vs.
controls). Approximately half of the DES birds were active (MA:
4/9, CCM: 4/9) which was also significantly different from
controls (p=0.01). Three out of the 9 birds treated with PPT or
DPN showed MA (p=0.0365) but never reached the end of the
copulatory sequence (no M and no CCM) and were therefore not
different from controls in this respect.
There was an overall significant effect of the treatments on the
mean cumulative frequencies of consummatory sexual behaviors
(MA: H=33.32, df=4, p,0.0001; CCM: H=36.00, df=4,
p,0.0001). Post-hoc comparisons with the control group revealed
significant differences between the T and CX/PG control group
(MA and CCM: p,0.001) while mean cumulative frequencies of
these behavior patterns were not different from controls in the
other groups exposed to estrogenic stimulation (p.0.05 in all
cases; see results for MA and CCM in Figure 3C–D).
Aromatase immunoreactivity
Overall, the endocrine manipulations significantly affected the
volume of the POM defined by the dense cluster of aromatase-
immunoreactive cells (F(4,30)=10.80; p,0.0001). Post-hoc com-
parisons with the control group revealed that a significant increase
in POM volume was present in the T group as compared to the
CX/PG group (p,0.0001; see Figure 4A). The volume of the
POM was, however, not different from the control group (p.0.05)
in birds treated with DES, PPT or DPN.
Vasotocin immunoreactivity
The vasotocinergic innervation of the POM, another steroid
sensitive parameter, was quantified by measuring the relative
optical density of the vasotocin-immunoreactive fibers in a
standardized region of the nucleus observed at high magnification.
An overall significant effect of the endocrine treatments was
detected in this analysis (F(4,45)=4.068; p=0.0067). Post-hoc
Figure 3. Percentage of birds that displayed at least one mount attempt (A) or one cloacal contact movement (B) and cumulative
frequencies of these two behaviors in the 5 experimental groups (C–D). Data were analyzed by appropriate analyses of variance or x2 tests
that were followed by post-hoc tests specifically comparing the 4 experimental groups to the controls (see text). Results of these post-hoc
comparisons are shown at the top of the bars as follows: *= p,0.05, **= p,0.01 and ***= p,0.001.
doi:10.1371/journal.pone.0018627.g003
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innervation in T-treated birds as compared to the control group
(p,0.01 see Figure 4B). The relative optical density of the
vasotocinergic innervation was numerically higher in the DES-
treated group than in controls but the difference did not reach
statistical significance. PPT and DPN did not affect this measure.
Discussion
We demonstrate here that the independent activation of
estrogen receptors alpha or beta significantly affects separate
aspects of male sexual behavior. This is the first study using specific
ER agonists PPT and DPN to investigate independently the role of
ERa and ERb in the control of male sexual behavior in adult
Japanese quail and, to our knowledge, in any vertebrate.
Activation of ERa increased the expression of appetitive aspects
of male behavior while both ERa and ERb agonists, separately,
enhanced the performance of the initial behavior patterns (NG
and MA) in the copulatory sequence. Interestingly, the vasotoci-
nergic innervation of the medial preoptic nucleus, a well-defined
estrogen-dependent response, was no significantly affected by the
general estrogen receptor agonist DES although the relative
optical density was numerically higher compared to the controls.
The independent activation of each receptor by specific agonists
did not result in any increase.
Appetitive sexual behavior
Male sexual behavior can be divided into an appetitive and a
consummatory component. The appetitive aspect consists of
searching and approaching a female while the consummatory
aspect is the copulation sensus stricto [59–61]. Both aspects are
known to depend on the presence of the estrogenic metabolites of
testosterone [62–64] but the specific implication of each estrogen
receptor subtype has not been investigated.
In quail, appetitive sexual behavior has been quantified by the
measure of two specific behaviors: the learned social proximity
response [62,64–66] and the rhythmic cloacal sphincter move-
ments (RCSM; [48,55,67]). These sphincter muscle contractions
are used by reproductively active males just before copulation. The
rhythmic contractions produce a foam that is transferred to the
female cloaca and enhances fertilization success [55]. Both the
social proximity response and RCSM disappear in castrated birds
and are restored by treatment with exogenous testosterone [48].
While the activation of the social proximity response by
testosterone requires the aromatization of the steroid [62,68],
the steroid specificity of RCSM activation and its dependence on
estrogenic metabolites of testosterone is not so clearly established.
One study showed that injection of testosterone-treated birds with
an aromatase inhibitor decreases the expression of RCSM but this
effect was only observed after 2–3 weeks of treatment with the
inhibitor [69]. It is therefore possible that the blockade of
testosterone metabolism did not affect directly the expression of
RCSM but simply blocked the copulatory behavior sensu stricto,
leading to a decrease of the reinforcing stimulus value of the
female (see [69] for discussion). It was also shown that conditioned
RCSM expressed after exposure to an arbitrary conditioned
stimulus previously paired with the view of a female are inhibited
by treatments with an aromatase inhibitor [56] but the effects
of estrogens on this response have never been tested to our
knowledge.
We show here for the first time that a general estrogen receptor
agonist, DES, significantly increases the number of castrated males
displaying RCSM in response to the visual presentation of a
female. However, the frequency of these cloacal contractions was
extremely low in comparison with birds treated with testosterone
suggesting that other aspects of testosterone action (binding of
testosterone or other androgenic metabolites to the androgen
receptor) are likely to be critical for the activation of this behavior.
The effects of DES were largely mimicked by injections of the ERa
agonist PPT (increase in percentage of active birds but very low
frequency of contractions), strongly suggesting that the activation
of ERa is required to trigger RCSM in response to the female. On
the other hand, no significant effect of the ERb agonist DPN was
observed on this behavior suggesting that this receptor is possibly
not (less) implicated in the activation of this form of appetitive
behavior.
Interestingly, the cloacal gland area increased markedly in
testosterone-treated birds but remained small in animals treated
Figure 4. Volume of the medial preoptic nucleus (POM) as
defined by the dense group of aromatase-immunoreactive
neurons (A) and relative optical density of the vasotocin-
immunoreactive fibers in the POM of the 5 experimental
groups (B). Data were analyzed by one-way analyses of variance
followed by post-hoc Dunnett’s tests comparing the 4 experimental
groups to the controls. Results of these post-hoc comparisons are
shown at the top of the bars as follows: *= p,0.05 and ***= p,0.001.
Since a number of brain samples were lost due to technical problems,
the number of data points available for each group is shown on the
corresponding bar in the graph.
doi:10.1371/journal.pone.0018627.g004
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controls. This confirms the strict androgen-dependence of the
morphological development of this gland [51,52] whereas the
activation of its contractions would be, at least in part, an estrogen-
dependent phenomenon presumably resulting from an action of
the steroids in the central nervous system. One key site of this
action is likely to be the medial preoptic nucleus based on the fact
that its lesion significantly inhibits the production of RCSM [48].
Importantly, we know that this nucleus expresses very high levels
of both estrogen receptors subtypes, making it a ideal target for
estrogen actions on appetitive behaviors, including RCSM
([28,29,70,71] see below).
Consummatory sexual behavior
A large number of studies have established that consummatory
aspects of male sexual behavior are activated in castrated male
quail by both testosterone and estrogens [1,3,8]. Additionally,
effects of testosterone on these behaviors are blocked by the
concurrent administration of either aromatase inhibitors [8,72] or
anti-estrogens [73,74] thus indicating that testosterone must be
aromatized into estrogens to exert these behavioral effects.
Accordingly, we show here that both testosterone and DES-
treated birds displayed the full copulatory sequence. It should
however be noted that behavior activation in the DES-injected
group concerned a smaller percentage of subjects that displayed
the behaviors with much lower frequencies than testosterone-
treated birds, as was the case in preceding studies [74]. The two
specific ER agonists activated NG and MA roughly to the same
extent as DES (640% of birds active but with low frequencies) but
had absolutely no effect on the expression of CCM. This would
suggest that both ER subtypes are playing a similar role in the
activation of consummatory behavior but the low level and
incomplete activation of copulatory sequence obtained here limits
the significance of this conclusion (see also below).
Central effects of specific ER agonists
POM volume as defined by aromatase. We also
investigated the effect of PPT and DPN administration on the
volume of the medial preoptic nucleus (POM) as defined by
aromatase immunoreactivity. As mentioned in the introduction,
the POM boundaries are outlined by the presence of a dense
group of aromatase-immunoreactive neurons. Aromatase activity
and the numbers of aromatase-immunoreactive cells in POM are
enhanced by testosterone and this effect of testosterone is mediated
by the synergistic action of its androgenic (5a-DHT) and
estrogenic (E2) metabolites both in birds including quail [75,76]
and in mammals [77] with the most prominent role being played
by estrogens in birds. The induction of aromatase expression in
POM usually parallels and is thought to contribute markedly to
the activation of male copulatory behavior [78,79].
Somewhat surprisingly, we observed here only minimal effects
of DES administration on the POM volume defined by aromatase-
immunoreactive neurons and PPT or DPN had absolutely no
effect on this measure despite the fact that testosterone-treated
birds showed, as expected [12,78] a doubling of POM volume.
The exact mechanism of estrogen action on aromatase expression
is unclear. Aromatase-immunoreactive neurons co-express andro-
gen receptors [80] but their colocalization with estrogen receptors
is less well defined in the POM. Both ERa and ERb are densely
expressed in the POM [28,70,71,81]. However, cells expressing
ERa do not exhibit a colocalization with aromatase in this region
(they are located in adjacent but different cells [81], and the co-
localization with ERb has not been investigated to this date. These
data therefore suggest that it is possible to activate weakly some
aspects of male sexual behavior without increasing aromatase
expression as measured by the volume occupied by imunoreactive
perikarya. This weak induction would therefore depend on the
activation of other cell types.
Vasotocinergic innervation of POM. As expected based on
previous studies [18], the density of vasotocin-immunoreactive
fibers was increased here following treatment with testosterone
and to some extent with the general estrogen receptor agonist
DES. Injections of specific ER agonists had however no effect on
the density of vasotocinergic fibers. These fibers originate mostly
in neurons located in the medial part of the BST [82]. The type(s)
of estrogen receptors expressed by these neurons has not been
investigated in quail although this nucleus presents an intense
expression of both ERa and ERb [28,71,81].
Similarly in mammals, the exact implication of a specific type of
receptor involved in the control of vasopressin, the mammalian
homologue of vasotocin, in the BST is currently not clear. The
presence of a functional estrogen response element in the
promoter region of vasopressin suggests a direct control of
expression by estrogens and it was actually reported that both
ERa and ERb were able to enhance the transcription [83].
Vasopressin-synthesizing cells from the BST, as defined by the
presence of neurophysin-immunoreactive material (vasopressin
transporter) were shown to express ERa [84] but these receptors
were apparently not present in the magnocellular vasopressin
neurons of the supraoptic and paraventricular nuclei. In contrast,
these magnocellular neurons express ERb [85–87] but studies of
ERb in the BST have apparently not been carried out. It is
interesting to note here that, although previous work indicates that
the sexual differentiation of the vasotocinergic parvocellular
system during development is controlled by estrogens [88] the
injection of PPT in quail eggs had no effect on the density of these
fibers in adult quail [89].
Neuroanatomical distribution of ERa and ERb in quail
and the neural site of estrogen action
The distribution of estrogen binding sites was first described in
quail by in vivo autoradiographic procedures that did not
discriminate between the two receptors subtypes [90]. The
development of immunohistochemistry and in situ hybridization,
as well as the discovery of two estrogen receptor subtypes
subsequently allowed a more precise localization and functional
understanding of estrogen action. In the quail brain, the
distribution of ERa and ERb has been studied by in situ
hybridization localizing brain areas that express the corresponding
mRNA [28,29,71] and, for ERa only, by immunohistochemistry
of the receptor protein [70,81]. All these studies concur to indicate
that both receptor subtypes are present in all nuclei that have been
shown to be implicated in the control of male reproductive
behavior by lesion and/or steroid implantation experiments. A
similar situation has been observed in the other vertebrate,
including rats and mice [30].
The nuclei expressing these receptors include the medial
preoptic nucleus (POM) that has been implicated in the control
of appetitive and consummatory aspects of male sexual behavior
(see review in [13,63]), the medial nucleus of the stria terminalis,
whose lesion decreases expression of copulatory behavior [48], and
the nucleus taeniae of the amygdala that seems implicated in the
control of both appetitive and consummatory sexual behavior
although conflicting results have been reported for this nucleus
[67,91].
Based on these neurochemical data, it is impossible to determine
the anatomical sites where specific ERa and ERb agonists act to
activate appetitive and/or consummatory sexual behavior. The
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estrogens agonists were shown to activate aspects of male sexual
behavior [92]. However, the wide distribution of the two ERs and
of aromatase, in parallel with the observation that testosterone acts
at multiple levels in the brain to control behavior strongly suggests
that other brains sites must be implicated and the precise
localization of neural substrate affected by steroids deserve
additional study.
Behavioral effects of ERa and ERb activation in other
species
Since the discovery of a second ER, numerous studies have tried
to delineate precisely the role of each receptor in the control of
various estrogen-dependent physiological and behavioral respons-
es. ERa and ERb knock-out (KO) mouse models as well as double
knock-outs (ERabKO) have played an important role in this
research and demonstrated an implication of one or both receptors
in the control of male and female sexual behavior [93–97], male
aggressive behavior [98–100], social interactions and anxiety
[101,102] and in the activity of various neurochemical systems
[103,104].
It was originally assumed that ERb was mainly inhibiting ERa
action [31] but the situation was later shown to be more complex.
Multiple studies have now demonstrated that the two subtypes of
ERs may act independently, synergistically or antagonistically to
regulate brain function and behavior [37,105]. One limitation of
these studies is, however, that they cannot discriminate between
organizational and activational effects of the steroids and that the
suppression of the receptors from the earliest developmental stages
might activate compensatory mechanisms. The transient activa-
tion of one of the two receptor subtypes with specific agonists
avoids these problems these problems and has also been used in a
number of behavioral and physiological studies in mammals.
Studies with these specific agonists have confirmed the
existence of a dissociation of the functions of ERa and ERb.
For example, PPT (ERa agonist) but not DPN (ERb agonist)
elicits sexual proceptivity (ear wiggling, hopping and darting)
and receptivity (lordosis) in the female rat [43,106,107].
Furthermore, the co-administration of DPN with PPT de-
creased the PPT-induced expression of both proceptive and
receptive female sexual behavior, suggesting that ERb could be
a modulator of ERa-dependent expression on female sexual
behavior [43]. Surprisingly, this approach has, to our knowl-
edge, never been used to study the activation of estrogen-
dependent aspects of adult male sexual behavior. It should
however be noted that in ovo treatment with PPT demasculinized
male copulatory behavior in Japanese quail [89].
… and in quail?
The present results suggest that both ERa and ERb are
implicated in the control of brain and behavior in quail. The
activation of these two receptors subtypes has similar effects on
some responses (mount attempts) but different impacts on others
(RCSM). The magnitude of these effects was however limited and
additionally a number of responses that are known to be estrogen-
dependent were not affected here by PPT or DPN. Several factors
must be considered to interpret this partial specificity and small
magnitude of effects.
First, the doses of PPT and DPN that were selected here for
testing (250 mg/birds/day i.e., 61.25 mg/kg/day considering an
average body weight of 200 g) might have been insufficient to fully
reveal the effects of the activation of ERa and ERb. These doses
were however in the range of doses used in previous studies
demonstrating effects on various behavioral or neurochemical
responses in mammals (e.g., [43,44,46,47,108]). In addition, they
were selected in an attempt to preserve the selectivity of these two
agonists. Even if PPT has approximately 350–400 times more
affinity for the ERa than for ERb (Ki relative to estradiol of
respectively 0.50 and 700 nM) and conversely DPN has 70–80
times more affinity for ERb than ERa (respective Ki equal to 2.5
and 195 nM) (see [35,41,42]) some cross-reactivity will occur in
vivo if subjects are injected with higher doses.
It is also noteworthy that DES has a higher affinity for the two
receptors (0.13 and 0.15 nM for ERa and ERb respectively,
similar to estradiol; [26] compared to the specific agonists for their
respective receptors (PPT: Relative binding affinity for ERa where
E2 is 100%: 20–50%; DPN: Relative binding affinity for ERb
where E2 is 100%: 5–20%; [41,42,109]. This lower affinity of the
specific agonists for their receptor should contribute to explain the
smaller amplitude of behavioral and physiological response
compared to the general agonist DES. In addition, no information
is to our knowledge available on the stability of the agonists in
vivo.
The doses selected here ensured a reasonable discrimination of
receptor activation at physiological concentrations. Because effects
observed here had a small amplitude (namely compared to DES
and T), one can thus be reasonably sure that effects were mediated
by the activation of the receptor that was targeted. Future work
should however investigate the effects of higher doses in order to
ascertain whether the limited amplitude of effects observed here
reflects the intrinsic properties of these compounds or relates to the
doses that were used.
Alternatively, it is also possible that some of the responses
investigated here may be stimulated following a simultaneous
activation of both ERa and ERb. This would explain why DES
and estradiol itself activate a number of responses that were not
affected here by the specific agonists. The study of female behavior
in rats rather suggests that DPN inhibits PPT action on female
sexual behavior [43] but synergistic effects might also exist for
other responses.
Conclusion
Altogether, these results suggest a key role of both receptors at
different level in the control of male sexual behavior although they
do not allow to fully discriminate between the specific roles of ERa
and ERb. The relatively weak activation of the behaviors observed
here might be due to the use of insufficient doses of agonists, to a
requirement for synergistic activation of both ERa and ERb or to
differences between avian and mammalian receptors. Future
studies should address these questions by a combination of
behavioral and biochemical approaches.
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